Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 04, 2024 6:34pm
RE:RE:Drug conjugate compounds for stimulating the antitumor ...
Interesting. But why does this not translate into a deal yet. The only thing that could do something for us apart from the advancement of science. We need a deal to endorse the
...more
(234)
•••
scarlet1967
X
View Profile
View Bullboard History
Comment by
scarlet1967
on Jun 04, 2024 5:42pm
RE:Drug conjugate compounds for stimulating the antitumor ...
The link. WO2024103161A1 - Drug conjugate compounds for stimulating the antitumor immune response - Google Patents WO2024103161A1 - Drug conjugate compounds for stimulating the antitumor immune
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(234)
•••
scarlet1967
X
View Profile
View Bullboard History
Post by
scarlet1967
on Jun 04, 2024 5:38pm
Drug conjugate compounds for stimulating the antitumor ...
"Despite significant progresses made in the treatment of cancers with the development of immune checkpoint inhibitors (ICI), several cancers exhibit resistance to these agents. Certain tumors are
...more
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on Jun 03, 2024 6:21pm
BIOTECH COMPANIES IN 'DARWINIAN' WORLD AS CASH REMAINS KING
BIOTECH COMPANIES IN 'DARWINIAN' WORLD AS CASH REMAINS KING About 31% of biotechs across U.S. and Europe have insufficient cash to maintain their operations for more than one year as access
...more
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 03, 2024 5:54pm
RE:RE:RE:RE:RE:Progression free survival rate
Exciting no... the Russian way.. burned to the ground....
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 02, 2024 4:31pm
RE:RE:RE:RE:Progression free survival rate
I read this and hobnestly i don't know what to make out of it and not much explanation for the the regular Joe in there. I think we'll need sales to pay the dept and somthing else to
...more
(72)
•••
Lee430
X
View Profile
View Bullboard History
Comment by
Lee430
on Jun 02, 2024 1:35pm
RE:RE:RE:Progression free survival rate
Hmm try again, https://meetings.asco.org/search?q=theratechnologies&filters=%7B%22contentTypeGroupLabel%22:%5B%7B%22key%22:%22General%20Information%22%7D,%7B%22key%22:%22Abstracts%20%26
...more
(72)
•••
Lee430
X
View Profile
View Bullboard History
Comment by
Lee430
on Jun 02, 2024 1:32pm
RE:RE:Progression free survival rate
Link to Thera's two ASOC abstracts. [url=https://https://meetings.asco.org/search?q=theratechnologies&filters=%7B%22contentTypeGroupLabel%22:%5B%7B%22key%22:%22General%20Information%22%7D,%7B
...more
(51)
•••
Qwerty54321
X
View Profile
View Bullboard History
Comment by
Qwerty54321
on Jun 01, 2024 10:55pm
RE:Progression free survival rate
I get ur point but you have to look at what other lung cancer drugs are capable of doing. It's the limited affects of other drugs that make this one look good (in lung cancer).
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 01, 2024 2:51pm
RE:RE:Progression free survival rate
I don't know why but I was under the impression that Marsolais was eager to tell us about new compelling data from Th1902 at ASCO. I must have dreamed that because nothing posted about that
...more
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Jun 01, 2024 10:25am
RE:Progression free survival rate
Do we have something on their posters... something like those compelling news that could make us richer than 40 cents....
(234)
•••
scarlet1967
X
View Profile
View Bullboard History
Post by
scarlet1967
on Jun 01, 2024 9:40am
Progression free survival rate
This bispecific antibody stops immunosuppression and blood supply process both responsible for progression of the cancer. The drug is now approved in combo therapy for cancer in
...more
(133)
•••
Trogarzon
X
View Profile
View Bullboard History
Post by
Trogarzon
on May 31, 2024 4:04pm
Pouet Pouet week again
Tomorrow ASCO.. last call for a partner and another dilution... Q2 sales should be good... lol...
(2)
•••
CreatingApe
X
View Profile
View Bullboard History
Post by
CreatingApe
on May 30, 2024 3:46pm
Wino?
I understand why you have been taking a break from this board. Trust me. But are you still in this with us? Miss all of your input, hope you are well and that you are just avoiding this messaging
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer